Washington covid-19 vaccine prevention Washington

FDA panel to review Pfizer COVID-19 vaccine data for children 5-11

Reading now: 602
www.fox29.com

WASHINGTON - The Food and Drug Administration is hosting a public meeting Tuesday that is a key step in deciding whether to open COVID-19 vaccinations to kids aged 5 to 11.The FDA is asking a panel of outside vaccine experts to review its analysis and vote on whether to recommend the Pfizer-BioNTech COVID-19 vaccine for the nation’s roughly 28 million children in that age range before the agency makes a decision.

If the FDA authorizes the shots, the U.S. Centers for Disease Control and Prevention will make additional recommendations on who should receive them the first week of November.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA